Coronavirus Update: Moderna’s COVID-19 Vaccine Passes First Test In Elderly Patients
Encouraging Results From Phase I Study
Executive Summary
Plus: Korea approves Celltrion antibody trial in mild patients, promising signs for Translate Bio's mRNA candidate in animal studies.
You may also be interested in...
US COVID Vaccine Early Distribution Plans Assume Emergency Use Authorization First
CDC developing vaccine distribution plans with four states and one large city that will serve as a ‘foundation’ for other jurisdictions; plans include provisions for all potential vaccines, but logistics will vary depending on product, especially given the cold chain issues associated with mRNA vaccines from Pfizer and Moderna.
Coronavirus Update: Moderna Could Have Advantage Over Pfizer’s Cold Chain
Cold chain distribution requirements are a major downside for mRNA-based vaccines, but Moderna may have the edge over Pfizer/BioNTech's candidate.
Executives On The Move: New CEOs At Advicenne, Almirall And CohBar
Executive reshuffle at Karyopharm Therapeutics, plus new chief financial officers at Redx Pharma and Vaccibody.